1038 related articles for article (PubMed ID: 17118349)
21. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana.
Dissanayake S; Shahin A; Ameen AM
Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
24. Co-infected C57BL/6 mice mount appropriately polarized and compartmentalized cytokine responses to Litomosoides sigmodontis and Leishmania major but disease progression is altered.
Lamb TJ; Graham AL; Le Goff L; Allen JE
Parasite Immunol; 2005 Sep; 27(9):317-24. PubMed ID: 16149989
[TBL] [Abstract][Full Text] [Related]
25. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
26. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
27. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection.
Buxbaum LU
Parasite Immunol; 2010 Feb; 32(2):153-60. PubMed ID: 20070829
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
Menon JN; Bretscher PA
Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages.
Shimizu Y; Takagi H; Nakayama T; Yamakami K; Tadakuma T; Yokoyama N; Kojima N
Parasite Immunol; 2007 May; 29(5):229-39. PubMed ID: 17430546
[TBL] [Abstract][Full Text] [Related]
30. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
32. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
34. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
[TBL] [Abstract][Full Text] [Related]
35. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
[TBL] [Abstract][Full Text] [Related]
36. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.
Alexander J; Brombacher F; McGachy HA; McKenzie AN; Walker W; Carter KC
Eur J Immunol; 2002 Oct; 32(10):2923-33. PubMed ID: 12355446
[TBL] [Abstract][Full Text] [Related]
37. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
Daneshvar H; Coombs GH; Hagan P; Phillips RS
J Infect Dis; 2003 May; 187(10):1662-8. PubMed ID: 12721947
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.
Gessner A; Will A; Vieth M; Schröppel K; Röllinghoff M
Immunology; 1995 Mar; 84(3):416-22. PubMed ID: 7751025
[TBL] [Abstract][Full Text] [Related]
39. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
[TBL] [Abstract][Full Text] [Related]
40. The scavenger receptor MARCO is involved in Leishmania major infection by CBA/J macrophages.
Gomes IN; Palma LC; Campos GO; Lima JG; DE Almeida TF; DE Menezes JP; Ferreira CA; Santos RR; Buck GA; Manque PA; Ozaki LS; Probst CM; DE Freitas LA; Krieger MA; Veras PS
Parasite Immunol; 2009 Apr; 31(4):188-98. PubMed ID: 19292770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
